Webb3 jan. 2024 · Shanghai Ark Biopharmaceutical in-licensed Greater China rights to a novel once-daily attention deficit hyperactivity disorder (ADHD) treatment Azstarys from Commave Therapeutics of Geneva.... Webb14 jan. 2024 · 2024年1月13日，来自香港的云涌控股有限公司 Shanghai Ark Biopharmaceutical Co., Ltd. (简称”云涌游戏”)向港交所递交招股书，拟在香港主板挂牌上 …

云涌游戏 Saka Saka，再次递交招股书，拟香港IPO上市

Webb7 okt. 2024 · Ark Biopharmaceutical is a biopharmaceutical company focusing on discovering and developing novel drugs for unmet medical needs, especially in pediatric and respiratory diseases. Since its... WebbShanghai City, China Responsible for building Bloomberg presense in Shanghai through connecting decision makers between on-shore and off-shore, providing market transparency to facilitate... dynasty harmony fireplace

Ark Biopharmaceutical Enters Into Exclusive License Agreement …

WebbJim Zhen Wu founded Shanghai Ark Biopharmaceutical Co., Ltd. Dr. Wu is Chairman & Chief Executive Officer at this company. In the past Dr. Wu held the position of Senior Director-Virus R&D Department... Webb12 feb. 2024 · 1月13日，雲湧控股有限公司Shanghai Ark Biopharmaceutical Co。 ， Ltd。 （以下簡稱“雲湧遊戲”） 向港交所遞交招股書，擬於港股上市。 獨家保薦人為富德金融。 於2024年6月29日，雲湧遊戲曾首度遞交招股書，目前已顯示為“失效”。 招股書顯示，Saka Limited持有云湧遊戲86%的股份。 公司創始人兼CEO曾勵星、其母親許夢霞分別持 … Webb29 dec. 2024 · SHANGHAI, December 28, 2024 -- Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”), an innovative biopharmaceutical company with a depth of expertise in … dynasty hip hop